Brainsway BRSYF
NASDAQ BRSYF
$15.13 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Brainsway (BRSYF) Income towards Parent Company (2018 - 2026)

Brainsway's (BRSYF) quarterly Income towards Parent Company came in at $2.7 million in Q2 2026, up 33.7% on a YoY basis from $2.0 million in Q2 2025, and up 18.34% quarter-over-quarter from $2.3 million in Q1 2026.

Analysis

Brainsway (BRSYF) Income towards Parent Company (2018 - 2026) Analysis & Trends

Brainsway (BRSYF) has reported Income towards Parent Company for 9 consecutive years, with $2.7 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Income towards Parent Company rose 33.7% year-over-year to $2.7 million; the trailing twelve-month figure through Jun 2026 stood at $9.5 million (up 77.75% YoY), and the FY2025 full-year result was $7.6 million, up 159.33% from the prior year.
  • Income towards Parent Company grew to $2.7 million in Q2 2026 per BRSYF's latest filing, from $2.3 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $2.9 million in Q4 2025 and bottomed at -$5.0 million in Q3 2022.
  • Historically, Income towards Parent Company has averaged -$110666.7 across 5 years, with a median of $363500.0 in 2023.
  • The sharpest annual moves came in 2022 and 2024: Income towards Parent Company sank 187.08% in 2022, then jumped 1118.9% in 2024.
  • Over 5 years, Income towards Parent Company stood at -$3.9 million in 2022, then jumped by 103.28% to $127000.0 in 2023, then surged by 1118.9% to $1.5 million in 2024, then soared by 89.47% to $2.9 million in 2025, then decreased by 7.6% to $2.7 million in 2026.
  • According to Business Quant data, Income towards Parent Company over the past three periods registered $2.7 million, $2.3 million, and $2.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 181.40 Bn 175.80 Bn 7.27 Bn
2 Intuitive Surgical 127.77 Bn 122.55 Bn 1.96 Bn
3 Medtronic 117.21 Bn 108.39 Bn 6.34 Bn
4 Stryker 105.12 Bn 101.64 Bn 4.50 Bn
5 Boston Scientific 64.52 Bn 63.98 Bn 3.85 Bn
6 Edwards Lifesciences 49.95 Bn 45.69 Bn 1.35 Bn
7 Alcon 33.09 Bn 31.63 Bn 1.68 Bn
8 Dexcom 32.17 Bn 30.23 Bn 830.00 Mn
9 Steris 20.75 Bn 20.27 Bn 684.20 Mn
10 Brainsway 592.58 Mn 529.41 Mn 12.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.71 Mn
Mar 31, 2026 2.29 Mn
Dec 31, 2025 2.93 Mn
Sep 30, 2025 1.57 Mn
Jun 30, 2025 2.03 Mn
Mar 31, 2025 1.11 Mn
Dec 31, 2024 1.55 Mn
Sep 30, 2024 662,000.00
Jun 30, 2024 600,000.00
Mar 31, 2024 111,000.00
Dec 31, 2023 127,000.00
Sep 30, 2023 -230,000.00
Jun 30, 2023 -1.66 Mn
Mar 31, 2023 -2.43 Mn
Dec 31, 2022 -3.87 Mn
Sep 30, 2022 -5.04 Mn
Jun 30, 2022 -2.45 Mn
Mar 31, 2022 -1.99 Mn
Dec 31, 2021 -1.35 Mn
Sep 30, 2021 -1.80 Mn